Saputalo, Mamerto G.

HRN: 24-23-79  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/29/2025
06/05/2025
IV
1.5gm
Q8h
HAP
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  PneumoniaMultiple Infections (tick All Sites)    Compliance to guidelines: